:

Nicholas J Croucher1

  • 1MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK.

PubMed
概括

开发新的细菌疫苗是一项挑战. 一种新的策略,即"免疫界面干扰" (I3) 疫苗,准阻断免疫反应的细菌机制,可能提高疫苗对感染的疗效.